Virginia Schad

PharmD

Most Recent Articles by Virginia Schad

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

By

In this phase 3 study, statistically and clinically meaningful improvements in HbA1c, body weight, and the proportion of patients achieving goal HbA1c <7% (53mmol/mol) were demonstrated with 2 doses of ITCA 650 vs placebo.

Higher BUN May Increase Risk for Incident Diabetes

Higher BUN May Increase Risk for Incident Diabetes

By

Findings showed that as the estimated glomerular filtration rate decreased and the blood urea nitrogen level increased, the risk for incident diabetes became progressively more pronounced.

Higher Risk for Stroke, MI in Patients With Gout, Diabetes

Higher Risk for Stroke, MI in Patients With Gout, Diabetes

By

Patients with both gout and diabetes are at a much higher risk for stroke and myocardial infarction than with diabetes alone.

Subclinical Primary Aldosteronism Increases Hypertension Risk in Normotensive Patients

Subclinical Primary Aldosteronism Increases Hypertension Risk in Normotensive Patients

By

Future studies using a renin phenotype-driven approach may efficiently identify new-onset or mild hypertension.

Positive Antihyperglycemic, Metabolic Effects With Ranolazine in Patients With Diabetes

Positive Antihyperglycemic, Metabolic Effects With Ranolazine in Patients With Diabetes

By

While there is increasing positive data for the utilization of ranolazine, a majority of the data did not come from large randomized controlled trials that looked at metabolic parameters as their primary end point.

More Articles by Virginia Schad

Sign Up for Free e-Newsletters

CME Focus